TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 SEK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
49,672
|
38,009
|
43,802 |
| Financial expenses |
184
|
69
|
158 |
| Earnings before taxes |
1,058
|
864
|
1,997 |
| EBITDA |
992
|
588
|
2,155 |
| Total assets |
86,521
|
71,190
|
56,098 |
| Current assets |
86,521
|
71,190
|
56,098 |
| Current liabilities |
45,970
|
30,991
|
18,274 |
| Equity capital |
40,551
|
40,199
|
37,824 |
| - share capital |
252
|
254
|
248 |
| Employees (average) |
11
|
16
|
16 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
46.9%
|
56.5%
|
67.4% |
| Turnover per employee |
4,516
|
2,376
|
2,738 |
| Profit as a percentage of turnover |
2.1%
|
2.3%
|
4.6% |
| Return on assets (ROA) |
1.4%
|
1.3%
|
3.8% |
| Current ratio |
188.2%
|
229.7%
|
307.0% |
| Return on equity (ROE) |
2.6%
|
2.1%
|
5.3% |
| Change turnover |
11,663
|
-5,793
|
2,650 |
| Change turnover % |
31%
|
-13%
|
6% |
| Chg. No. of employees |
-5
|
0
|
-2 |
| Chg. No. of employees % |
-31%
|
0%
|
-11% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.